Announcements Trials

Browse Landscape

Phase

Status

Recruiting 5 Active not recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 17 Carboplatin 13 Paclitaxel 12 Cisplatin 12 Radiation 10 Doxorubicin 10 Cyclophosphamide 9 Radiotherapy 8 Vincristine 7 Nivolumab 7 Metformin 7 Etoposide 7 Cytarabine 7 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 6 Leucovorin 6 Injections 6 Fluorouracil 6 tislelizumab 5 Prednisone 5 Pemetrexed 5 Methotrexate 5 Ipilimumab 5 Cetuximab 5 Bevacizumab 5 fludarabine 4 durvalumab 4 atezolizumab 4 Specimen Handling 4 Radiotherapy, Conformal 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × alectinib × 30 days × Clear all

NCT02075840 2026-05-29

ALEX

Hoffmann-La Roche

Phase 3 Completed

303 enrolled 32 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡